1-39 of 39
Keywords: neurodegeneration
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem J (2024) 481 (6): 461–480.
Published: 18 March 2024
... in MJD and also appears to be involved in cancer. As aberrant deubiquitination has been linked to both neurodegeneration and cancer, a comprehensive understanding of ataxin-3's DUB function is important for elucidating potential therapeutic targets in these complex conditions. In this review, we aim...
Articles
Biochem J (2024) 481 (3): 141–160.
Published: 29 January 2024
... and mice similarly result in neurodegeneration, CSP is evidently an evolutionarily conserved neuroprotective protein. However, the client proteins that CSP chaperones to prevent neurodegeneration remain unclear. Traditional methods for identifying protein–protein interactions, such as yeast 2-hybrid...
Includes: Supplementary data
Articles
Biochem J (2023) 480 (19): 1485–1501.
Published: 04 October 2023
... a transformative agreement with JISC. cervid CWD Drosophila melanogaster infectivity neurodegeneration prion Prion diseases are fatal transmissible neurodegenerative conditions of mammalian species that include Creutzfeldt–Jakob disease (CJD) of humans, bovine spongiform encephalopathy (BSE...
Articles
Biochem J (2022) 479 (1): 75–90.
Published: 14 January 2022
... this cross-talk is disrupted, in the context of disease. apoptosis autophagic cell death autophagy cancer necroptosis neurodegeneration Correspondence: Nektarios Tavernarakis ( [email protected] ) 14 11 2021 21 12 2021 23 12 2021 © 2022 The Author(s...
Articles
Biochem J (2021) 478 (14): 2945–2951.
Published: 30 July 2021
... for this article was enabled by the participation of University College London in an all-inclusive Read & Publish pilot with Portland Press and the Biochemical Society under a transformative agreement with JISC. leucine-rich repeat kinase neurodegeneration Parkinson's disease Leucine-rich...
Articles
Biochem J (2021) 478 (14): 2733–2758.
Published: 23 July 2021
... proposed as a potential strategy to slow down the progression of neurodegeneration. Through the development and application of tools that allow dissection of the mechanistic roles of this PTM, there is now a growing body of evidence that O -GlcNAc influences a variety of important neurodegeneration...
Articles
Biochem J (2021) 478 (10): 1959–1976.
Published: 28 May 2021
... amphisome autophagy late endosome neurodegeneration neurotrophic signaling retrograde axonal transport Macroautophagy, hereafter referred to as autophagy, is a major cytosolic degradative system involving sequestration of damaged cellular components and dysfunctional organelles within...
Articles
Biochem J (2020) 477 (4): 833–852.
Published: 28 February 2020
... with Portland Press and the Biochemical Society under a transformative agreement with JISC. Drosophila melanogaster neurodegeneration prion transcriptomics Protein misfolding neurodegenerative diseases are invariably fatal conditions that include Alzheimer's disease, Huntington's disease...
Includes: Supplementary data
Articles
Biochem J (2019) 476 (22): 3493–3504.
Published: 27 November 2019
...-dependent neurodegeneration, where astrocytes lose key molecules involved in regulation of glutamate/glutamine homeostasis, neuronal survival and synaptogenesis. Astrocytic dysfunction in tauopathy appears to precede neurodegeneration and overt tau neuropathology such as phosphorylation, aggregation...
Articles
Biochem J (2019) 476 (5): 859–873.
Published: 12 March 2019
...-rich proteins granulin neurodegeneration progranulin Granulins (GRNs 1–7) are a family of small unique cysteine-rich proteins that are proteolytically cleaved from the precursor protein, progranulin (PGRN) ( Supplementary Figure S1A ) [ 1 ]. All seven GRNs (GRNs 1–7) are ∼6 kDa in size...
Includes: Supplementary data
Articles
Biochem J (2018) 475 (19): 3087–3103.
Published: 10 October 2018
... ( [email protected] ) or Niv Papo ( [email protected] ) 26 3 2018 2 9 2018 7 9 2018 13 9 2018 © 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2018 Aβ42 peptide Alzheimer's disease amyloids neurodegeneration neuronal cell...
Includes: Supplementary data
Articles
Biochem J (2017) 474 (8): 1417–1438.
Published: 07 April 2017
... RBPs with PrLDs. We also highlight the potential of protein disaggregases, including Hsp104, as a therapeutic strategy to combat the aberrant phase transitions of RBPs with PrLDs that likely underpin neurodegeneration. Correspondence: James Shorter ( [email protected] ) 9 1 2017...
Articles
Biochem J (2017) 474 (3): 333–355.
Published: 20 January 2017
... transport system covers a diverse array of proteins involved in metabolic support, neurotransmission and synaptic architecture. Therefore, specific targeting of individual transporter families has the potential to suppress neurodegeneration, a characteristic hallmark of AD. A small number of the 400...
Articles
Biochem J (2016) 473 (22): 4083–4101.
Published: 10 November 2016
... article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND) . cancer functional genomics neurodegeneration proteomics proteostasis ubiquitin Conjugation of the small protein modifier...
Articles
Articles
Biochem J (2016) 473 (11): 1563–1578.
Published: 27 May 2016
...) and alternative drug candidates compared with current biopharmaceutical treatments. Aβ peptide lipocalin neurodegeneration protein engineering Alzheimer's disease (AD) is the most prevalent form of dementia, with 10% of the human population older than 65 years and 40% older than 85 years affected...
Includes: Supplementary data
Articles
Articles
Biochem J (2014) 462 (3): 489–497.
Published: 22 August 2014
... disease models. apoptosis DJ-1 neurodegeneration neuron receptor of activated C kinase 1 (RACK1) Animals were maintained in the Animal Care Facility at our institute, and all experiments involving animals were approved by Institutional Animal Care and Use Committee at the Institute...
Articles
Biochem J (2014) 462 (1): 67–75.
Published: 24 July 2014
... seizures and neurodegeneration [ 15 ]. Neurons account for most of the SeP expression in the mouse brain [ 16 ]. This finding was substantiated when SeP biosynthesis was inactivated selectively in neurons through the conditional inactivation of tRNA [Ser]Sec [ 17 ]. Specifically, PV (parvalbumin...
Includes: Multimedia, Supplementary data
Articles
Biochem J (2014) 460 (2): 141–156.
Published: 13 May 2014
... 20C (Fam20C) genuine casein kinase (G-CK) neurodegeneration In the second half of the 19th Century, the findings of Ulaf Hammarsten [ 1 ] that phosphorus was present in the milk protein casein, in addition to carbon, nitrogen, hydrogen, oxygen and sulfur, came as a surprise. Henceforth...
Includes: Supplementary data
Articles
Biochem J (2013) 450 (2): 253–264.
Published: 15 February 2013
... fibrosis inflammation meprin metalloprotease neurodegeneration proteomics Proteolysis is an irreversible post-translational modification that affects every single cell of an organism. Over the last decades proteolytic enzymes have been identified to be master switches in the regulation...
Includes: Multimedia, Supplementary data
Articles
Articles
Biochem J (2012) 441 (2): 523–540.
Published: 21 December 2011
... of the Creative Commons Attribution Non-Commercial Licence ( http://creativecommons.org/licenses/by-nc/2.5/ ) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. autophagy mitochondrion neurodegeneration nitrative...
Articles
Articles
Articles
Biochem J (2011) 433 (1): 19–29.
Published: 15 December 2010
..., Huntington's and Parkinson's diseases, and the rarer prion diseases, are separate entities clinically but have common features, including aggregates of misfolded proteins and varying patterns of neurodegeneration. A key barrier to effective treatment is that patients present clinically with advanced...
Includes: Supplementary data
Articles
Biochem J (2010) 429 (3): 545–552.
Published: 14 July 2010
... tremor/ataxia syndrome (FXTAS) mitochondrion neurodegeneration oxidative stress trinucleotide repeat expansion unfolded protein response FXTAS (fragile X-associated tremor/ataxia syndrome) is a late-onset neurodegenerative disorder [ 1 – 5 ] that affects individuals who are carriers...
Includes: Supplementary data
Articles
Biochem J (2010) 428 (1): 85–93.
Published: 28 April 2010
... 2010 9 3 2010 © The Authors Journal compilation © 2010 Biochemical Society 2010 (3) Excessive generation of NO • in neuroinflammation, excitotoxicity, and during aging and age-related neurodegeneration entails the up-regulation of the inducible (iNOS) and neuronal (nNOS...
Articles
Biochem J (2009) 422 (1): 11–22.
Published: 29 July 2009
... neurodegeneration selenium selenocysteine selenoprotein thyroid hormone Eukaryotic selenoprotein genes require a SECIS element in the 3′-UTR of the mRNA in order to recode the UGA stop codon for Sec insertion. This unique stem–loop structure is the binding site for SBP2 (SECIS-binding protein 2...
Includes: Multimedia, Supplementary data
Articles
Articles
Biochem J (2005) 392 (3): 675–683.
Published: 06 December 2005
...Judit Oláh; Ferenc Orosz; László G. Puskás; László Hackler, Jr; Margit Horányi; László Polgár; Susan Hollán; Judit Ovádi Triosephosphate isomerase (TPI) deficiency is a unique glycolytic enzymopathy coupled with neurodegeneration. Two Hungarian compound heterozygote brothers inherited the same TPI...
Includes: Supplementary data
Articles
Biochem J (2005) 386 (2): E5.
Published: 22 February 2005
... neurodegeneration selenium selenium transport selenoprotein selenoprotein P Selenium (Se) is an essential micronutrient that is required in a variety of metabolic functions that includes its role in antioxidant defences (for a review see [ 1 ]). Se is incorporated into an interesting class of molecules...
Articles
Articles
Articles
Biochem J (2003) 372 (1): 129–136.
Published: 15 May 2003
... for this neurodegeneration. The PrP 106–126, a synthetic peptide obtained from the amyloidogenic region of the PrP, constitutes a model system to study prion-induced neurodegeneration as it retains the ability to trigger cell death in neuronal cultures. In the present study, we show that the addition of this prion peptide...
Articles
Biochem J (2002) 362 (2): 253–258.
Published: 22 February 2002
... to the pathological modifications in prion disease. Key words: copper, manganese, neurodegeneration, scrapie, superoxide. METHODS Infection of mice C57BL}6 male and 129Sv female mice were purchased from Harlan UK (Shaw s Farm, Bicester, Oxon., U.K.) and cross- bred in-house to generate F1 wild-type progeny that were...
Articles
Biochem J (2002) 362 (2): 459–464.
Published: 22 February 2002
... was slow (2 h). It is concluded that NO is consumed in the brain through a novel protein, ultimately forming NO $ , and that the slow regeneration of the activity provides a scenario for NO to become toxic. Key words: cGMP, neurodegeneration, respiration. The brain is particularly enriched...
Articles
Biochem J (2001) 359 (1): 1–16.
Published: 24 September 2001
...: cancer, diabetes, insulin, neurodegeneration, Wnt. Akt) [9]. Subsequent work has elucidated the phosphatidyl- inositide (PI) 3-kinase-dependent pathway by which PKB is activated by insulin (Figure 1; for reviews, see [10,11 Thus, in response to insulin, the inhibition of GSK3 promotes...
Articles
Biochem J (1999) 344 (3): 625–631.
Published: 08 December 1999
... residue, and it is suggested that this may cause a toxic gain of function in NTE. The Biochemical Society, London © 1999 1999 active site gain of function neural development neurodegeneration protein family Biochem. J. (1999) 344, 625 631 (Printed in Great Britain) 625 REVIEW ARTICLE...